INDV Earnings Indivior Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | 0.69 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | 1.64 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-30 | 0.85 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.52 | 2025-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.38 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | 0.05 | 2026-02-26 | 10-K |
| Q3 2025 | 2024-09-30 | -0.11 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.27 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.45 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | -0.92 | 2026-02-26 | 10-K |
| Q3 2025 | 2022-12-31 | -0.30 | 2025-10-30 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.